Cyclacel Pharmaceuticals (CYCC) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
On January 25, 2024, Dr. Brian Schwartz, a member of the Company’s board of directors, was appointed as the interim Chief Medical Officer with immediate effect, resulting in him no longer being regarded as an independent director during his tenure.
For further insights into CYCC stock, check out TipRanks’ Stock Analysis page.
For a comprehensive understanding of the announcement, you can read the full document here.
